Home > Products > Tumor Cell Lines > Human Tumor Cell Lines >
NCI-H209 |
||||
|---|---|---|---|---|
| Product Name |
NCI-H209 |
|||
| Price | Get Quote | |||
| Product Code | H209; H-209; NCIH209 |
|||
| Cat.No |
ABC-TC603S |
Species |
Human |
|
| Size/Quantity |
1 vial |
|||
| Shipping Info |
Dry Ice |
Storage |
Liquid Nitrogen |
|
| Description |
Human Lung small cell carcinoma cell line. The NCI-H209 cell line was derived by A.F. Gazdar and associates in 1979 from the bone marrow of a patient with small cell cancer of the lung. The bone marrow specimen was taken prior to therapy. The line is a classic SCLC cell line which expresses elevated levels of four biochemical markers (neuron specific enolase, brain isoenzyme of creatine kinase, L-DOPA decarboxylase and bombesin-like immunoreactivity. C-myc DNA sequences are not amplified. No gross structural DNA abnormalities were detected. This is a cell line that grows as large aggregates in suspension. Only the aggregates are viable, but no meaningful viability percentage can be measured. The medium will normally contain large amounts of cell debris. The cells express an aberrant form of RB1 that is not phosphorylated, apparently due to a single point mutation at codon 706 (Cys -> Phe). |
|||
| Disease | Lung Small Cell Cancer |
|||
| Recommended Medium And Supplement | RPMI 1640 + 10% FBS |
|||
| Citation Guide |
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID). |
|||
| Application | For research use only |
|||
| Growth Conditions | 37 ℃, 5% CO2 |
|||
| Cell Type | Epithelial |
|||
| Product Type |
Human Lung Cancer Cell Lines |
|||
| Product Image |
|
|||
- ONLINE INQUIRY
- PRODUCT REVIEWS
Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.
